Neuromod readies tinnitus treatment device for launch
15 December 2014 | 0
Medical technology company Neuromod Devices is to create an additional 50 jobs for Dublin over the next five years. The announcement comes as the company’s first product mutebutton – a new device for the treatment of Tinnitus – is readied for release on 15 December.
The new roles will be key in supporting its global growth targets to become a leading global provider of non-surgical neuromodulation treatments for chronic conditions.
This project has been supported by the Department of Jobs, Enterprise and Innovation through Enterprise Ireland.
Mutebutton is a self-administered treatment designed to alleviate the symptoms of chronic tinnitus sufferers. It is the culmination of over four years of research and development by Dr Ross O’Neill.
Once purchased, the device is delivered to The Neuromod Clinic, where patients will be given an appointment to have the device configured to their needs by a qualified audiologist. This new development is in response to increased demand in the global medical device market for sophisticated and innovative medical devices.
The mutebutton system combines synchronous audio and lingual (tongue) stimulation to promote patient neuroplasticity, effectively ‘retraining’ the brain.
Used for a minimum of 30 minutes a day over a 10-week period, the treatment has been clinically proven to reduce the sounds of tinnitus in studies conducted by NUI Maynooth and the Hermitage Medical Centre Dublin.
Enterprise Ireland, Irish Medical Devices Association (IMDA) and IDA Ireland named Neuromod Devices as merging medical company of the year at the Medical Industry Excellence Awards 2014.